45% of all deaths in Europe are attributed to cardiovascular diseases! In our October Issue, we dive into tackling CVD in Europe with a 𝐧𝐞𝐰 𝐒𝐞𝐫𝐢𝐞𝐬 (of 4 papers) on 'Variations in cardiovascular disease outcomes across Europe' 👇 thelancet.com/journals/lanep…

Each of the 4 papers within this Series delves into a specific region, providing a meticulous examination of #Nordic countries, the #UK, western and southern #Europe, and eastern Europe. Read the full Series here: thelancet.com/series/europea…

These in-depth analyses in the Series underscore the critical importance of tailoring policies to suit each country's unique circumstances, rather than adopting a one-size-fits-all approach.

🧵/ Late breaking science results from #AHA23 will be posted to this thread at the time of presentation: SELECT MINT ORBITA-2 CRHCP Dementia POP-HT KARDIA-1 CARDIA-SSBP ARTESIA VERVE-101 ESPRIT SPEC-AI Nigeria SPEECH ⬇️ (bookmark this post)

In 70,953 pts with ACS, having all 4 CHD #riskfactors was associate with a 5yrs reduction in life expectancy w/o #ACS compared with no risk factors. Proud to be part of this team! The Lancet Reg Health-Europe Raffaele Bugiardini Edina Cenko thelancet.com/journals/lanep…

Net adverse clinical events with P2Y12 inhibitor therapy in older patients after percutaneous coronary interventions Edina Cenko Raffaele Bugiardini 🔗atherosclerosis-journal.com/article/S0021-… European Atherosclerosis Society Università di Bologna #CvPrev

#CardiacRehab is an essential life saving therapy after AMI & part of #GDMT 💃🏻 Women are less often referred compared with men 🫀 Save a woman’s heart by referring her to Cardiac Rehab #29DaysofHeart #savingwomenshearts #GoRed Smidt Heart Institute at Cedars-Sinai Cedars-Sinai has NO WAIT to get in! 👏🏽

📅 Apr 9, 16:00-17:00 CEST: ESC WG talk with Alfredo R Galassi & Raffaele Bugiardini on coronary physiology in CTOs. 🌟 Insights on CTO-PCI from Omer Goktekin and Stefano Barco. 🚀 Join for groundbreaking perspectives! ✅ Free registration for all. #CTO #CardioTwitter European Society of Cardiology

tinyurl.com/243tv4zf

Exploring CTOs: Evidence Strategies Timing & Outcomes in CTO PCI Dive into coronary physiology pre/post-CTO PCI in the ESC WG Talk. #CTO #Cardiology Join us on 09 April, 16:00 CEST Register for insights on practical application! tinyurl.com/243tv4zf European Society of Cardiology News European Society of Cardiology

Closing the sex gap in cardiovascular mortality Atherosclerosis 🫀Friendly debate between myself & Raffaele Bugiardini: Is it Sex or is it inequity in treatment that result in poorer outcomes in women? 🚨Answer: Likely a combination of the two! #WomensHeartHealth rb.gy/yjh2h5

Join the #ESC Working Group on Coronary Pathophysiology & Microcirculation on Tuesday 9 April at 16:00 CET for a live online talk on: Coronary Physiology in the Setting of CTO Register here 👉tinyurl.com/243tv4zf European Society of Cardiology #Cardiology

Announcing the The Lancet Reg Health-Europe commission led by Raffaele Bugiardini, with co-chairs Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 & Prof Chris P Gale, focuses on reducing inequalities in CV health—a crucial global public health challenge. #CVD #HealthEquity #CardioTwitter Università di Bologna Pooja Jha authors.elsevier.com/sd/article/S26…

We are excited to announce our 1st commission on inequalities & disparities in cardiovascular health focusing on marginalized populations: women, ethnic minorities, the elderly, and those with mental health conditions. Commission's objectives & scope 👇 thelancet.com/journals/lanep…

Current guidelines do not differ based on sex, but their applications based on gender do differ❗️ Vertical equity means tailoring healthcare to allow equitable care for all 🔗atherosclerosis-journal.com/article/S0021-… European Atherosclerosis Society Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Raffaele Bugiardini #EASSoMe #CvPrev

Horizontal equity in the context of CHD means that both men and women with comparable health statuses should have equal access to diagnosis, treatment, and management of CHD 🔗atherosclerosis-journal.com/article/S0021-… European Atherosclerosis Society Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Raffaele Bugiardini #EASSoMe #CVPrev

Has the time come for universal screening of 3 simple modifiable risk markers: hsCRP, LDL, and Lp(a)? A study in 27,939 initially healthy women show these 3 modifiable markers are predictive of long-term CV outcomes over 30 years. Watch Dr. Ridker discuss findings here

OCEANIC-AF trial shows factor XI inhibitor asundexian was inferior for preventing stroke and systemic embolism vs. apixaban in pts with Afib and high stroke risk. Trial stopped early due to inferiority of asunxdexian. #ESCCongress

🚨ASSURE-DES results now in JACC Journals: Continue aspirin or stop it after noncardiac surgery. #Cardiotwitter Harlan Krumholz

• Increasing awareness in 🧑‍⚕️👩‍⚕️ about women's unique CV care needs can address sex differences • The ultimate goal is to ensure 👬 and 👭 get equitable, effective CHD care, tailored to their needs and risks 🔗atherosclerosis-journal.com/article/S0021-… European Atherosclerosis Society Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Raffaele Bugiardini